Phathom Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
November 08, 2021 at 08:00 am EST
Phathom Pharmaceuticals, Inc. reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported net loss was USD 36.66 million compared to USD 34.11 million a year ago. Basic loss per share from continuing operations was USD 0.98 compared to USD 1.02 a year ago.
For the nine months, net loss was USD 108.06 million compared to USD 75.35 million a year ago. Basic loss per share from continuing operations was USD 2.94 compared to USD 2.29 a year ago.